Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Assets (2019 - 2025)

10x Genomics' Return on Assets history spans 7 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Assets rose 15.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, up 15.0%, while the annual FY2025 figure was 0.04%, 15.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.04% at 10x Genomics, up from 0.08% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.04% in Q4 2025 and bottomed at 0.57% in Q1 2021.
  • The 5-year median for Return on Assets is 0.17% (2023), against an average of 0.22%.
  • The largest YoY upside for Return on Assets was 49bps in 2021 against a maximum downside of -49bps in 2021.
  • A 5-year view of Return on Assets shows it stood at 0.06% in 2021, then crashed by -183bps to 0.16% in 2022, then tumbled by -63bps to 0.27% in 2023, then grew by 26bps to 0.2% in 2024, then surged by 79bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for TXG's Return on Assets are 0.04% (Q4 2025), 0.08% (Q3 2025), and 0.09% (Q2 2025).